Skip to main content
main-content

Master Topic Page

News

06-12-2018 | Rheumatoid arthritis | News

Targeting B cells may delay RA development in those at risk

B-cell directed therapy with a single infusion of rituximab significantly delays the development of rheumatoid arthritis in people at high risk for developing the condition, exploratory study data show.

Source:

Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2017-212763

04-12-2018 | Ankylosing spondylitis | News

Elevated CRP levels may point to better secukinumab response in AS patients

Ankylosing spondylitis patients with elevated C-reactive protein levels may experience greater benefits from treatment with the interleukin-17A inhibitor secukinumab than those with lower levels of the inflammatory marker, researchers report.

Source:

RMD Open 2018; 4: e000749

03-12-2018 | Rheumatoid arthritis | Highlight | News

Chronic opioid use rising in RA patients

Chronic opioid use among patients with rheumatoid arthritis increased substantially between 2002 and 2015, researchers report.

Source:

Arthritis Rheumatol 2018; doi:10.1002/art.40789

30-11-2018 | Rheumatoid arthritis | News

Biomarker score reflects rituximab response in RA patients

Changes in the multi-biomarker disease activity score could be used to track response to rituximab treatment in patients with rheumatoid arthritis, researchers report.

Source:

Arthritis Res Ther 2018; 20: 256

27-10-2018 | Denosumab | ACR/ARHP 2018 | Video

Support for denosumab as a treatment option for osteoporosis in patients treated with glucocorticoids

Kenneth Saag discusses his findings of a superior bone mineral density benefit at 2 years with denosumab versus risedronate in patients with glucocorticoid-related osteoporosis (4:45).

25-10-2018 | Rheumatoid arthritis | ACR/ARHP 2018 | Video

Improving immune response against influenza in patients with RA

Inés Colmegna talks to us about her study showing the impact of a high-dose influenza vaccine on the immune response of patients with rheumatoid arthritis (11:17).

24-10-2018 | Cardiovascular disease | ACR/ARHP 2018 | Video

Looking to collaborative models of care to improve primary prevention of CVD in patients with inflammatory arthritis

Lihi Eder describes a new model of care based on collaboration between cardiologists and rheumatologists to better manage cardiovascular risk factors in patients with inflammatory arthritis (5:56).

image credits